CD274 and central nervous system cancer: IDH1/2 mutations reduced the release of CXCL10 that attract the accumulation of CTLs (Kohanbash et al., 2017), and increased the production of PD-L1 (Berghoff et al., 2017), hinting the involvement of glioma cell metabolism in the dysfunction of CTLs.